These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8203331)

  • 1. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
    Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
    Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
    Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
    Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.
    Johansson SR; Wiklund O; Karlsson T; Hjalmarson A; Emanuelsson H
    Eur Heart J; 1991 Sep; 12(9):1020-8. PubMed ID: 1936002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.
    Dzavik V; Teo KK; Yokoyama S; Modi R; Dinwoodie A; Burton JR; Tymchak WJ; Montague TJ
    Am J Cardiol; 1995 May; 75(14):936-8. PubMed ID: 7733005
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
    Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
    Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
    J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group.
    Daida H; Lee YJ; Yokoi H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F; Kato H; Kutsumi Y
    Am J Cardiol; 1994 Jun; 73(15):1037-40. PubMed ID: 8198026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1994 Nov; 90(5):2267-79. PubMed ID: 7955183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
    Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
    Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serum lipid levels on restenosis after coronary angioplasty.
    Reis GJ; Kuntz RE; Silverman DI; Pasternak RC
    Am J Cardiol; 1991 Dec; 68(15):1431-5. PubMed ID: 1746423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Normalization of lipid metabolism disturbances and clinical course after percutaneous coronary angioplasty: 6 month observation].
    Ochała A; Gabrylewicz B; Bartnik M; Garbocz P; Wycisk A; Lewicki A; Kaźmierski M; Tendera M
    Pol Arch Med Wewn; 2000 Dec; 104(6):833-41. PubMed ID: 11424662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial].
    Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G
    J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of restenosis by bezafibrate after successful coronary angioplasty.
    Ishiwata S; Nakanishi S; Nishiyama S; Seki A
    Coron Artery Dis; 1995 Nov; 6(11):883-9. PubMed ID: 8696533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Klein JL; Kosinski AS; King SB; Ivanhoe R; Cedarholm JC; Stillabower ME; Talley JD; DeMaio SJ
    N Engl J Med; 1994 Nov; 331(20):1331-7. PubMed ID: 7935702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.
    Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H
    Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty.
    Tenda K; Saikawa T; Maeda T; Sato Y; Niwa H; Inoue T; Yonemochi H; Maruyama T; Shimoyama N; Aragaki S
    Jpn Circ J; 1993 Aug; 57(8):789-95. PubMed ID: 8355396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
    Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
    Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.